ALMLB Fundamental Analysis - MILIBOO SA

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to ALMLB. ALMLB was compared to 32 industry peers in the Household Durables industry. While ALMLB seems to be doing ok healthwise, there are quite some concerns on its profitability. ALMLB is valued correctly, but it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALMLB had negative earnings in the past year.

ALMLB had a negative operating cash flow in the past year.

The reported net income has been mixed in the past 5 years: ALMLB reported negative net income in multiple years.

In multiple years ALMLB reported negative operating cash flow during the last 5 years.

1.2 Ratios

ALMLB has a worse Return On Assets (-1.63%) than 81.25% of its industry peers.

ALMLB has a Return On Equity of -3.99%. This is amonst the worse of the industry: ALMLB underperforms 81.25% of its industry peers.

		Industry Rank	Sector Rank
ROA	-1.62%
ROE	-3.99%
ROIC	N/A

ROA(3y)0.92%

ROA(5y)2.07%

ROE(3y)-1.1%

ROE(5y)23.81%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ALMLB's Gross Margin of 26.58% is on the low side compared to the rest of the industry. ALMLB is outperformed by 65.63% of its industry peers.

In the last couple of years the Gross Margin of ALMLB has remained more or less at the same level.

ALMLB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	26.58%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.1%

GM growth 5Y1.16%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALMLB does not have a ROIC to compare to the WACC, probably because it is not profitable.

ALMLB has about the same amout of shares outstanding than it did 1 year ago.

Compared to 5 years ago, ALMLB has more shares outstanding

The debt/assets ratio for ALMLB has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 3.56 indicates that ALMLB is not in any danger for bankruptcy at the moment.

ALMLB has a better Altman-Z score (3.56) than 81.25% of its industry peers.

A Debt/Equity ratio of 0.15 indicates that ALMLB is not too dependend on debt financing.

ALMLB's Debt to Equity ratio of 0.15 is amongst the best of the industry. ALMLB outperforms 84.38% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.15
Debt/FCF	N/A
Altman-Z	3.56

ROIC/WACCN/A

WACC7.2%

2.3 Liquidity

ALMLB has a Current Ratio of 1.85. This is a normal value and indicates that ALMLB is financially healthy and should not expect problems in meeting its short term obligations.

With a decent Current ratio value of 1.85, ALMLB is doing good in the industry, outperforming 65.63% of the companies in the same industry.

A Quick Ratio of 0.92 indicates that ALMLB may have some problems paying its short term obligations.

Looking at the Quick ratio, with a value of 0.92, ALMLB is in line with its industry, outperforming 56.25% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.85
Quick Ratio	0.92

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for ALMLB have decreased strongly by -111.64% in the last year.

The Revenue for ALMLB has decreased by -10.02% in the past year. This is quite bad

ALMLB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.42% yearly.

EPS 1Y (TTM)-111.64%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-135.27%

Revenue 1Y (TTM)-10.02%

Revenue growth 3Y-0.18%

Revenue growth 5Y5.42%

Sales Q2Q%-7.29%

3.2 Future

The Earnings Per Share is expected to decrease by -31.83% on average over the next years. This is quite bad

The Revenue is expected to decrease by -8.53% on average over the next years.

EPS Next Y17.64%

EPS Next 2Y0.93%

EPS Next 3Y-31.83%

EPS Next 5YN/A

Revenue Next Year-8.57%

Revenue Next 2Y-6.23%

Revenue Next 3Y-8.53%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALMLB. In the last year negative earnings were reported.

Based on the Price/Forward Earnings ratio of 6.16, the valuation of ALMLB can be described as very cheap.

Based on the Price/Forward Earnings ratio, ALMLB is valued cheaper than 87.50% of the companies in the same industry.

The average S&P500 Price/Forward Earnings ratio is at 23.88. ALMLB is valued rather cheaply when compared to this.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	6.16

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

ALMLB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

ALMLB's earnings are expected to decrease with -31.83% in the coming years. This may justify a cheaper valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y0.93%

EPS Next 3Y-31.83%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALMLB!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

MILIBOO SA

EPA:ALMLB (1/9/2026, 7:00:00 PM)

1.92

+0.02 (+1.05%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Durables & Apparel

GICS IndustryHousehold Durables

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners43%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap13.31M

Revenue(TTM)38.98M

Net Income(TTM)-260.00K

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	6.16
P/S	0.34
P/FCF	N/A
P/OCF	N/A
P/B	2.02
P/tB	3.04
EV/EBITDA	N/A

EPS(TTM)-0.04

EYN/A

EPS(NY)0.31

Fwd EY16.24%

FCF(TTM)-0.18

FCFYN/A

OCF(TTM)-0.06

OCFYN/A

SpS5.62

BVpS0.95

TBVpS0.63

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-1.62%
ROE	-3.99%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	26.58%
FCFM	N/A

ROA(3y)0.92%

ROA(5y)2.07%

ROE(3y)-1.1%

ROE(5y)23.81%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.1%

GM growth 5Y1.16%

F-Score2

Asset Turnover2.44

Health

		Industry Rank	Sector Rank
Debt/Equity	0.15
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	161.54%
Cap/Sales	2.15%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.85
Quick Ratio	0.92
Altman-Z	3.56

F-Score2

WACC7.2%

ROIC/WACCN/A

Cap/Depr(3y)200.35%

Cap/Depr(5y)208.57%

Cap/Sales(3y)2.1%

Cap/Sales(5y)2.06%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-111.64%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-135.27%

EPS Next Y17.64%

EPS Next 2Y0.93%

EPS Next 3Y-31.83%

EPS Next 5YN/A

Revenue 1Y (TTM)-10.02%

Revenue growth 3Y-0.18%

Revenue growth 5Y5.42%

Sales Q2Q%-7.29%

Revenue Next Year-8.57%

Revenue Next 2Y-6.23%

Revenue Next 3Y-8.53%

Revenue Next 5YN/A

EBIT growth 1Y-118.54%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year85.04%

EBIT Next 3Y-21.17%

EBIT Next 5YN/A

FCF growth 1Y-215.07%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-117.96%

OCF growth 3YN/A

OCF growth 5YN/A

MILIBOO SA / ALMLB.PA FAQ

What is the ChartMill fundamental rating of MILIBOO SA (ALMLB.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALMLB.PA.

Can you provide the valuation status for MILIBOO SA?

ChartMill assigns a valuation rating of 4 / 10 to MILIBOO SA (ALMLB.PA). This can be considered as Fairly Valued.

How profitable is MILIBOO SA (ALMLB.PA) stock?

MILIBOO SA (ALMLB.PA) has a profitability rating of 1 / 10.

How financially healthy is MILIBOO SA?

The financial health rating of MILIBOO SA (ALMLB.PA) is 5 / 10.

MILIBOO SA (ALMLB.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

MILIBOO SA / ALMLB.PA FAQ

What is the ChartMill fundamental rating of MILIBOO SA (ALMLB.PA) stock?

Can you provide the valuation status for MILIBOO SA?

How profitable is MILIBOO SA (ALMLB.PA) stock?

How financially healthy is MILIBOO SA?